Several reports describe an higher risk for viral infections in patients with asthma.1,2 Novel coronavirus disease (COVID-19) is caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), that shows a predilection to infect the lower and upper airway tract, thus creating an higher clinical issue in asthmatic patients.3.
COVID-19 in severe asthmatic patients during ongoing treatment with biologicals targeting type 2 inflammation: results from a multicenter Italian survey
Vianello, A;Guarnieri, G;
2020
Abstract
Several reports describe an higher risk for viral infections in patients with asthma.1,2 Novel coronavirus disease (COVID-19) is caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), that shows a predilection to infect the lower and upper airway tract, thus creating an higher clinical issue in asthmatic patients.3.
File in questo prodotto:
Non ci sono file associati a questo prodotto.
Pubblicazioni consigliate
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
